To sign up     Investment     Messages    HR

 

Culture
In 2009, the company officially settled in hangzhou national hi-tech industry development zone, hangzhou qiming medical instrument co., LTD. Was set up.
Qiming medical is a professional committed to the medical device companies in the field of minimally invasive treatment of heart valve disease, in the domestic leading position, is the third session of the national innovation entrepreneurship competition biological pharmaceutical group of the national championship. Enterprise owns two of the world's first: the world's first preinstalled in valve system, the first step in the global expansion of pulmonary valve system. Four Chinese first: the first one to start and finish the China the CFDA registered clinical research, the first to obtain the CFDA innovation channel support cardiovascular devices, the first in Europe for human clinical Chinese heart valves implanted devices, the first approved to be established in China institute of heart valve enterprise.
Patent technology

Qiming medical is a professional committed to the medical device companies in the field of minimally invasive treatment of heart valve disease, in the domestic leading position, is the third session of the national innovation entrepreneurship competition biological pharmaceutical group of the national championship. Enterprise owns two of the world's first: the world's first preinstalled in valve system, the first step in the global expansion of pulmonary valve system. Four Chinese first: the first one to start and finish the CFDA registered clinical research in China, the first to obtain the CFDA innovation channel support cardiovascular devices, the first in Europe for human clinical Chinese heart valves implanted devices, the first approved to be established in China institute of heart valve enterprise.
190 qiming has patents, of which 168 invention, utility model 16, six effective PCT application, 65 patents has won ?
 

Production system
Qiming medical instrument co., LTD., is dedicated to research and development in valves, by means of science and technology innovation, take the quality as the lifeline of the enterprise.
Taking the unremitting pursuit of quality and innovation, and enlightenment of health in 2014, BSI notified body for iso13485:2003 2003 quality system certification, in March 2016 national medicine bureau registered at the scene of the quality system of the assessment.
Qiming medical products in strict accordance with the [2014] 64 "medical equipment production and the quality control standard" requirements for production control. Company percutaneous intervention of artificial heart valve system is the CFDA approved medical apparatus and instruments for innovation, become the first landing CFDA innovation medical instrument of the green channel.
As China's leading transcatheter heart valve manufacturing enterprise, qiming medical has previously won "the third session of the national innovation entrepreneurship